Cargando…
PDA Indolylmaleimides Induce Anti-Tumor Effects in Prostate Carcinoma Cell Lines Through Mitotic Death
Castrate resistant prostate cancer in men shares several characteristics with canine prostate cancer (PCa). Due to current insufficient therapies, evaluating novel therapeutic agents for late-stage PCa is of considerable interest for both species. PDA indolylmaleimides showed anticancer effects in s...
Autores principales: | Schille, Jan Torben, Nolte, Ingo, Beck, Julia, Jilani, Daria, Roolf, Catrin, Pews-Davtyan, Anahit, Rolfs, Arndt, Henze, Larissa, Beller, Matthias, Brenig, Bertram, Junghanss, Christian, Schütz, Ekkehard, Murua Escobar, Hugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855975/ https://www.ncbi.nlm.nih.gov/pubmed/33553272 http://dx.doi.org/10.3389/fvets.2020.558135 |
Ejemplares similares
-
Characterization of the novel indolylmaleimides' PDA-66 and PDA-377 effect on canine lymphoma cells
por: Liu, Wen, et al.
Publicado: (2016) -
The novel arylindolylmaleimide PDA-66 displays pronounced antiproliferative effects in acute lymphoblastic leukemia cells
por: Kretzschmar, Christin, et al.
Publicado: (2014) -
A Simple LC-MS/MS Method for the Quantification of PDA-66 in Human Plasma
por: Schwarz, Rico, et al.
Publicado: (2022) -
Isoquinolinamine FX-9 Exhibits Anti-Mitotic Activity in Human and Canine Prostate Carcinoma Cell Lines
por: Schille, Jan Torben, et al.
Publicado: (2019) -
Comparative High-Resolution Transcriptome Sequencing of Lymphoma Cell Lines and de novo Lymphomas Reveals Cell-Line-Specific Pathway Dysregulation
por: Taher, Leila, et al.
Publicado: (2018)